Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Nordic Bioscience A/S
DescriptionInjectable formulation of the intestinal hormone glucagon-like peptide-2 (GLP-2)
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationOsteoporosis
Indication DetailsTreat osteoporosis; Treat osteoporosis in postmenopausal women
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today